TrialWorld journal of gastroenterology2025

Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch.

Zhi-Hao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.